BAKX Therapeutics Inc.

Ipsen SA 's appetite for business development has not been sated and just over a month after agreeing to acquire Epizyme, Inc. , the French firm has furthered its cancer pipeline by getting access to

With valuations in freefall across the biotech sector, Ipsen SA has hit the M&A trail with its acquisition of US firm Epizyme, Inc. and its already-approved cancer drug Tazverik. The French group,

The perception of Ipsen SA as a conservative business has been turned on its head since David Loew took over as CEO in July 2020, with the French company becoming a flagbearer for mid-sized pharma b

New Galapagos CEO 'Within Weeks' Over two decades after founding Galapagos NV , one of the biggest success stories in Europe's biotech sector before a series of clinical and regulatory setbacks struc